Short-acting GLP-1 medications (exenatide immediate-release, lixisenatide) must be administered within 60 minutes before meals for optimal post-prandial glucose control
Department of Endocrinology, Mymensingh Medical College, Charpara, Mymensingh Sadar, Mymensingh 2200, Bangladesh Tel: +880-1711103905, Fax: +880-9166064, E-mail: [email protected] Received: September 29, 2024 Revised: October 11, 2024 Accepted: November 14, 2024 Copyright 2025 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited
She said: Obesity is a chronic relapsing condition, and I think one would expect that these treatments need to be continued for life, just in the same way as blood pressure medication
The semaglutide to tirzepatide conversion chart can help with dose matching, but supplement needs remain consistent regardless of which GLP-1 medication you use
Kojic Acid Traditionally used to improve the look of pigmentation and brighten the skin tone
GLP-1 obesity drugs provide a twofold benefit